Eribulin mesylate (halichondrin B Analog E7389) in platinum-resistant epithelial ovarian cancer (PR-EOC): A CTEP-sponsored phase II study Meeting Abstract
| Authors: | Hensley, M. L.; Kravetz, S.; Sima, C.; Tew, W.; Pereira, L.; Sabbatini, P.; Whalen, C.; Aghajanian, C. A.; Zarwan, C.; Berlin, S. |
| Abstract Title: | Eribulin mesylate (halichondrin B Analog E7389) in platinum-resistant epithelial ovarian cancer (PR-EOC): A CTEP-sponsored phase II study |
| Meeting Title: | 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 27 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2009 May 29-Jun 2 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2009-05-20 |
| Start Page: | 292s |
| Language: | English |
| ACCESSION: | WOS:000276606600062 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2009.27.15_suppl.5561 |
| Notes: | Meeting Abstract: 5561 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
